Laura Elizabeth Rosen
Laura Elizabeth Rosen has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Francisco Olea-Popelka
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA
3 shared publications- Michele Ann Miller
South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
3 shared publications - Andrew William Byrne
Department of Agriculture Food and the Marine
2 shared publications - Arnoud H. M. van Vliet
Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK
2 shared publications Chris M. Foggin
Victoria Falls Wildlife Trust, Victoria Falls, Zimbabwe
2 shared publications- Daniel P. Walsh
U.S. Geological Survey, Montana Cooperative Wildlife Research Unit University of Montana Missoula Montana USA
2 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12
Using qualitative risk assessment to re-evaluate the veterinary fence paradigm within the Kavango Zambezi Transfrontier Conservation Area
Introduction: Habitat connectivity in southern Africa’s Kavango Zambezi Transfrontier Conservation Area (KAZA TFCA, or KAZA) is hindered by the presence of veterinary fences put in place to prevent transboundary animal disease transmission. In northern Botswana’s Ngamiland, much of the fencing infrastructure is in disrepair due to ineffective maintenance in the face of increased elephant damage, but specific sections of some fences still restrict critical wildlife movements. Methods: We undertook qualitative risk assessments for sections of the Northern Buffalo fence near the Okavango Delta and the Zambezi Border and Western Border fences along the Botswana-Namibia borders. We assessed multiple risk pathways for three main transboundary animal diseases (foot and mouth disease, contagious bovine pleuropneumonia and peste des petits ruminants) under three different scenarios: (1) the status quo (fences as they currently are), (2) with hypothetical removal of specific fence sections, and (3) with hypothetical removal of fence sections with risk mitigation measures instituted. Results: Our study found that hypothetical removal of these fence sections did not increase the risk of the transboundary animal diseases of interest, and that with the institution of specific risk mitigation measures (such as strategic livestock herding), the overall risk of some diseases would be lower compared to the status quo. Each pathway contained critical steps with low, very low or negligible risk which influenced the overall risk for the pathway. Discussion: Based on low estimated risks, sections of all three fences could be considered for removal, but further information was needed for the Western Border fence. Key stakeholders established consensus to move forward with consultations with local communities and to offer assistance with the implementation of risk mitigation measures (such as improved herding, kraaling) conditionally associated with potential removal of key fence sections. Opening the fences in key low-risk areas would restore connectivity for elephants and other wildlife and potentially reduce human-wildlife conflict in areas where high densities of elephants are constrained by fences. This new, more sectorally integrative approach to livestock disease control is vital to wildlife’s ability to access key resources over space and time and thus to the sustained success of KAZA.
- 30 January 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12
Open AccessUsing qualitative risk assessment to re-evaluate the veterinary fence paradigm within the Kavango Zambezi Transfrontier Conservation Area
Introduction: Habitat connectivity in southern Africa’s Kavango Zambezi Transfrontier Conservation Area (KAZA TFCA, or KAZA) is hindered by the presence of veterinary fences put in place to prevent transboundary animal disease transmission. In northern Botswana’s Ngamiland, much of the fencing infrastructure is in disrepair due to ineffective maintenance in the face of increased elephant damage, but specific sections of some fences still restrict critical wildlife movements. Methods: We undertook qualitative risk assessments for sections of the Northern Buffalo fence near the Okavango Delta and the Zambezi Border and Western Border fences along the Botswana-Namibia borders. We assessed multiple risk pathways for three main transboundary animal diseases (foot and mouth disease, contagious bovine pleuropneumonia and peste des petits ruminants) under three different scenarios: (1) the status quo (fences as they currently are), (2) with hypothetical removal of specific fence sections, and (3) with hypothetical removal of fence sections with risk mitigation measures instituted. Results: Our study found that hypothetical removal of these fence sections did not increase the risk of the transboundary animal diseases of interest, and that with the institution of specific risk mitigation measures (such as strategic livestock herding), the overall risk of some diseases would be lower compared to the status quo. Each pathway contained critical steps with low, very low or negligible risk which influenced the overall risk for the pathway. Discussion: Based on low estimated risks, sections of all three fences could be considered for removal, but further information was needed for the Western Border fence. Key stakeholders established consensus to move forward with consultations with local communities and to offer assistance with the implementation of risk mitigation measures (such as improved herding, kraaling) conditionally associated with potential removal of key fence sections. Opening the fences in key low-risk areas would restore connectivity for elephants and other wildlife and potentially reduce human-wildlife conflict in areas where high densities of elephants are constrained by fences. This new, more sectorally integrative approach to livestock disease control is vital to wildlife’s ability to access key resources over space and time and thus to the sustained success of KAZA.
- Open Access
- 26 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-2
Reply to: Genomic insights into the 2020 mass die-off event among African elephants
- 26 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-2
Open AccessReply to: Genomic insights into the 2020 mass die-off event among African elephants
- Open Access
- 25 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-10
Pasteurella sp. associated with fatal septicaemia in six African elephants
The sudden mortality of African elephants (Loxodonta africana) in Botswana and Zimbabwe in 2020 provoked considerable public interest and speculation. Poaching and malicious poisoning were excluded early on in the investigation. Other potential causes included environmental intoxication, infectious diseases, and increased habitat stress due to ongoing drought. Here we show evidence of the mortalities in Zimbabwe as fatal septicaemia associated with Bisgaard taxon 45, an unnamed close relative of Pasteurella multocida. We analyse elephant carcasses and environmental samples, and fail to find evidence of cyanobacterial or other intoxication. Post-mortem and histological findings suggest a bacterial septicaemia similar to haemorrhagic septicaemia caused by P. multocida. Biochemical tests and 16S rDNA analysis of six samples and genomic analysis of one sample confirm the presence of Bisgaard taxon 45. The genome sequence contains many of the canonical P. multocida virulence factors associated with a range of human and animal diseases, including the pmHAS gene for hyaluronidase associated with bovine haemorrhagic septicaemia. Our results demonstrate that Bisgaard taxon 45 is associated with a generalised, lethal infection and that African elephants are susceptible to opportunistically pathogenic Pasteurella species. This represents an important conservation concern for elephants in the largest remaining metapopulation of this endangered species.
- 25 October 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-10
Open AccessPasteurella sp. associated with fatal septicaemia in six African elephants
The sudden mortality of African elephants (Loxodonta africana) in Botswana and Zimbabwe in 2020 provoked considerable public interest and speculation. Poaching and malicious poisoning were excluded early on in the investigation. Other potential causes included environmental intoxication, infectious diseases, and increased habitat stress due to ongoing drought. Here we show evidence of the mortalities in Zimbabwe as fatal septicaemia associated with Bisgaard taxon 45, an unnamed close relative of Pasteurella multocida. We analyse elephant carcasses and environmental samples, and fail to find evidence of cyanobacterial or other intoxication. Post-mortem and histological findings suggest a bacterial septicaemia similar to haemorrhagic septicaemia caused by P. multocida. Biochemical tests and 16S rDNA analysis of six samples and genomic analysis of one sample confirm the presence of Bisgaard taxon 45. The genome sequence contains many of the canonical P. multocida virulence factors associated with a range of human and animal diseases, including the pmHAS gene for hyaluronidase associated with bovine haemorrhagic septicaemia. Our results demonstrate that Bisgaard taxon 45 is associated with a generalised, lethal infection and that African elephants are susceptible to opportunistically pathogenic Pasteurella species. This represents an important conservation concern for elephants in the largest remaining metapopulation of this endangered species.
- Open Access
- 1 June 2020
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 179, 105004
Is moving from targeted culling to BCG-vaccination of badgers (Meles meles) associated with an unacceptable increased incidence of cattle herd tuberculosis in the Republic of Ireland? A practical non-inferiority wildlife intervention study in the Republic of Ireland (2011-2017)
- 1 June 2020
- Published by Elsevier in Preventive Veterinary Medicine
- Vol. 179, 105004
Open AccessIs moving from targeted culling to BCG-vaccination of badgers (Meles meles) associated with an unacceptable increased incidence of cattle herd tuberculosis in the Republic of Ireland? A practical non-inferiority wildlife intervention study in the Republic of Ireland (2011-2017)
- 26 November 2019
- Published by Springer Nature in European Journal of Wildlife Research
- Vol. 65 (6) , 97
Monitoring European badger (Meles meles) reproduction under evolving bovine tuberculosis management in Ireland
- 26 November 2019
- Published by Springer Nature in European Journal of Wildlife Research
- Vol. 65 (6) , 97
Monitoring European badger (Meles meles) reproduction under evolving bovine tuberculosis management in Ireland
- 1 March 2019
- Published by American Association of Zoo Veterinarians in Journal of Zoo and Wildlife Medicine
- Vol. 50 (1) , 23-32
SURVEY OF ANTITUBERCULOSIS DRUG ADMINISTRATION AND ADVERSE EFFECTS IN ELEPHANTS IN NORTH AMERICA
Tuberculosis, caused by Mycobacterium tuberculosis, is a disease causing morbidity and mortality in captive elephants (Elephas maximus and Loxodonta africana) as well as free-ranging individuals. Elephants in North America diagnosed with tuberculosis are often treated with antituberculosis drugs, unlike livestock species, which has necessitated the development of treatment guidelines adapted from recommendations for humans. There are few published reports describing empirical treatment, which may be complicated by poor patient compliance, interruptions in drug administration, and adverse effects. A survey of elephants in North America was conducted to compile information on treatment protocols, including drugs, dosages, routes of administration, serum drug concentrations, and adverse effects of antituberculosis treatment. Responses were received regarding 182 elephants, 12 of which were treated prophylactically or therapeutically with antituberculosis drugs. Treatment protocols varied among elephants, and included various combinations of isoniazid, rifampin, pyrazinamide, ethambutol, enrofloxacin, levofloxacin, and ethionamide. Serum drug concentrations also varied considerably among and within individuals. Facility staff reported 5 elephants (out of 7 treated elephants with responses) that exhibited clinical signs that may have been associated with antituberculosis drugs or treatment procedures. Anorexia, decreased water intake, constipation, depression, ataxia, limb paresis, and tremors were among the signs observed. Most adverse effects were reported to be moderate or severe, resulting in interruption of the treatment. The results from this survey provide veterinarians and elephant managers with valuable historical data to make informed clinical management decisions regarding antituberculosis therapy in elephants.
- 1 March 2019
- Published by American Association of Zoo Veterinarians in Journal of Zoo and Wildlife Medicine
- Vol. 50 (1) , 23-32
SURVEY OF ANTITUBERCULOSIS DRUG ADMINISTRATION AND ADVERSE EFFECTS IN ELEPHANTS IN NORTH AMERICA
Tuberculosis, caused by Mycobacterium tuberculosis, is a disease causing morbidity and mortality in captive elephants (Elephas maximus and Loxodonta africana) as well as free-ranging individuals. Elephants in North America diagnosed with tuberculosis are often treated with antituberculosis drugs, unlike livestock species, which has necessitated the development of treatment guidelines adapted from recommendations for humans. There are few published reports describing empirical treatment, which may be complicated by poor patient compliance, interruptions in drug administration, and adverse effects. A survey of elephants in North America was conducted to compile information on treatment protocols, including drugs, dosages, routes of administration, serum drug concentrations, and adverse effects of antituberculosis treatment. Responses were received regarding 182 elephants, 12 of which were treated prophylactically or therapeutically with antituberculosis drugs. Treatment protocols varied among elephants, and included various combinations of isoniazid, rifampin, pyrazinamide, ethambutol, enrofloxacin, levofloxacin, and ethionamide. Serum drug concentrations also varied considerably among and within individuals. Facility staff reported 5 elephants (out of 7 treated elephants with responses) that exhibited clinical signs that may have been associated with antituberculosis drugs or treatment procedures. Anorexia, decreased water intake, constipation, depression, ataxia, limb paresis, and tremors were among the signs observed. Most adverse effects were reported to be moderate or severe, resulting in interruption of the treatment. The results from this survey provide veterinarians and elephant managers with valuable historical data to make informed clinical management decisions regarding antituberculosis therapy in elephants.
- 16 November 2017
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 65 (2) , e344-e354
Tuberculosis serosurveillance and management practices of captive African elephants (Loxodonta africana) in the Kavango-Zambezi Transfrontier Conservation Area
Transfrontier conservation areas represent an international effort to encourage conservation and sustainable development. Their success faces a number of challenges, including disease management in wildlife, livestock and humans. Tuberculosis (TB) affects humans and a multitude of non-human animal species and is of particular concern in sub-Saharan Africa. The Kavango-Zambezi Transfrontier Conservation Area encompasses five countries, including Zimbabwe, and is home to the largest contiguous population of free-ranging elephants in Africa. Elephants are known to be susceptible to TB; thus, understanding TB status, exposure and transmission risks to and from elephants in this area is of interest for both conservation and human health. To assess risk factors for TB seroprevalence, a questionnaire was used to collect data regarding elephant management at four ecotourism facilities offering elephant-back tourist rides in the Victoria Falls area of Zimbabwe. Thirty-five working African elephants were screened for Mycobacterium tuberculosis complex antibodies using the ElephantTB Stat-Pak and the DPP VetTB Assay for elephants. Six of 35 elephants (17.1%) were seropositive. The risk factor most important for seropositive status was time in captivity. This is the first study to assess TB seroprevalence and risk factors in working African elephants in their home range. Our findings will provide a foundation to develop guidelines to protect the health of captive and free-ranging elephants in the southern African context, as well as elephant handlers through simple interventions. Minimizing exposure through shared feed with other wildlife, routine TB testing of elephant handlers and regular serological screening of elephants are recommended as preventive measures.
- 16 November 2017
- Published by Wiley in Transboundary and Emerging Diseases
- Vol. 65 (2) , e344-e354
Tuberculosis serosurveillance and management practices of captive African elephants (Loxodonta africana) in the Kavango-Zambezi Transfrontier Conservation Area
Transfrontier conservation areas represent an international effort to encourage conservation and sustainable development. Their success faces a number of challenges, including disease management in wildlife, livestock and humans. Tuberculosis (TB) affects humans and a multitude of non-human animal species and is of particular concern in sub-Saharan Africa. The Kavango-Zambezi Transfrontier Conservation Area encompasses five countries, including Zimbabwe, and is home to the largest contiguous population of free-ranging elephants in Africa. Elephants are known to be susceptible to TB; thus, understanding TB status, exposure and transmission risks to and from elephants in this area is of interest for both conservation and human health. To assess risk factors for TB seroprevalence, a questionnaire was used to collect data regarding elephant management at four ecotourism facilities offering elephant-back tourist rides in the Victoria Falls area of Zimbabwe. Thirty-five working African elephants were screened for Mycobacterium tuberculosis complex antibodies using the ElephantTB Stat-Pak and the DPP VetTB Assay for elephants. Six of 35 elephants (17.1%) were seropositive. The risk factor most important for seropositive status was time in captivity. This is the first study to assess TB seroprevalence and risk factors in working African elephants in their home range. Our findings will provide a foundation to develop guidelines to protect the health of captive and free-ranging elephants in the southern African context, as well as elephant handlers through simple interventions. Minimizing exposure through shared feed with other wildlife, routine TB testing of elephant handlers and regular serological screening of elephants are recommended as preventive measures.
- 1 April 2017
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 53 (2) , 372-376
Prevalence and Risk Factors forMycobacterium bovisInfection in African Lions (Panthera leo) in the Kruger National Park
Mycobacterium bovis, the causative agent of bovine tuberculosis (BTB), is endemic in the Kruger National Park (KNP), South Africa. African lions (Panthera leo) are susceptible to BTB, but the impact of the disease on lion populations is unknown. In this study, we used a novel gene expression assay for chemokine (C-X-C motif) ligand 9 (CXCL9) to measure the prevalence of M. bovis infection in 70 free-ranging lions that were opportunistically sampled in the southern and central regions of the KNP. In the southern region of the KNP, the apparent prevalence of M. bovis infection was 54% (95% confidence interval [CI]=36.9–70.5%), compared with 33% (95% CI=18.0–51.8%) in the central region, a significant difference (P=0.08). Prevalence of M. bovis infection in lions showed similar patterns to estimated BTB prevalence in African buffaloes (Syncerus caffer) in the same areas. Investigation of other risk factors showed a trend for older lions, males, or lions with concurrent feline immunodeficiency virus ...
- 1 April 2017
- Published by Wildlife Disease Association in Journal of Wildlife Diseases
- Vol. 53 (2) , 372-376
Prevalence and Risk Factors forMycobacterium bovisInfection in African Lions (Panthera leo) in the Kruger National Park
Mycobacterium bovis, the causative agent of bovine tuberculosis (BTB), is endemic in the Kruger National Park (KNP), South Africa. African lions (Panthera leo) are susceptible to BTB, but the impact of the disease on lion populations is unknown. In this study, we used a novel gene expression assay for chemokine (C-X-C motif) ligand 9 (CXCL9) to measure the prevalence of M. bovis infection in 70 free-ranging lions that were opportunistically sampled in the southern and central regions of the KNP. In the southern region of the KNP, the apparent prevalence of M. bovis infection was 54% (95% confidence interval [CI]=36.9–70.5%), compared with 33% (95% CI=18.0–51.8%) in the central region, a significant difference (P=0.08). Prevalence of M. bovis infection in lions showed similar patterns to estimated BTB prevalence in African buffaloes (Syncerus caffer) in the same areas. Investigation of other risk factors showed a trend for older lions, males, or lions with concurrent feline immunodeficiency virus ...
- 2 February 2017
- Published by Springer Nature in European Journal of Wildlife Research
- Vol. 63 (1) , 1-8
Weather influences trapping success for tuberculosis management in European badgers (Meles meles)
- 2 February 2017
- Published by Springer Nature in European Journal of Wildlife Research
- Vol. 63 (1) , 1-8
Weather influences trapping success for tuberculosis management in European badgers (Meles meles)